# Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

> **NCT00357084** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 53 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** methotrexate
- **DRUG:** methylprednisolone
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00357084
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-08
- **Final completion:** —
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2010-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00357084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00357084, "Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00357084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*